Glaucoma Trends in glaucoma drug prescriptions: U.S. ophthalmologists favor generics and newer agents
Diabetic Macular Edema EyePoint reports favorable 6-month results for Duravyu in Phase 2 trial for DME
Glaucoma Phase 2 trials of QLS-111 meet endpoints, showing promise for glaucoma and ocular hypertension treatment
Diabetic Macular Edema FDA approves Susvimo as first continuous delivery treatment for diabetic macular edema
Early Onset Cataracts Most ophthalmologists impose no long-term activity restrictions for pediatric eye surgery patients
